Immune landscape of inflammatory breast cancer suggests vulnerability to immune checkpoint inhibitors

Background. Anti-PD1/PDL1 immune checkpoint inhibitors (ICIs) showed promising results in breast cancer, and exploration of additional actionable immune checkpoints is ongoing. Inflammatory breast cancer (IBC) is an aggressive form of disease, the immune tumor microenvironment (TME) of which is poor...

全面介紹

Na minha lista:
書目詳細資料
發表在:Oncoimmunology
Main Authors: Bertucci, François, Boudin, Laurys, Finetti, Pascal, Van Berckelaer, Christophe, Van Dam, Peter, Dirix, Luc, Viens, Patrice, Gonçalves, Anthony, Ueno, Naoto T., Van Laere, Steven, Birnbaum, Daniel, Mamessier, Emilie
格式: Artigo
語言:Inglês
出版: Taylor & Francis 2021
主題:
Original Research
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC8158040/
https://ncbi.nlm.nih.gov/pubmed/34104544
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2021.1929724
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍